Leerink Partnrs Cuts Earnings Estimates for Cardinal Health

Cardinal Health, Inc. (NYSE:CAH) – Analysts at Leerink Partnrs decreased their Q3 2025 earnings estimates for shares of Cardinal Health in a report issued on Thursday, January 30th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $2.18 per share for the quarter, down from their previous estimate of $2.20. The consensus estimate for Cardinal Health’s current full-year earnings is $7.92 per share. Leerink Partnrs also issued estimates for Cardinal Health’s FY2025 earnings at $8.04 EPS, FY2026 earnings at $9.05 EPS, FY2027 earnings at $9.89 EPS and FY2028 earnings at $10.80 EPS.

A number of other equities research analysts have also recently weighed in on CAH. Mizuho began coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective for the company. Citigroup upped their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Morgan Stanley raised their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $135.93.

Cardinal Health Stock Down 0.0 %

Shares of NYSE CAH opened at $125.29 on Monday. The business has a 50-day moving average price of $122.16 and a 200 day moving average price of $114.75. The stock has a market cap of $30.27 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 1.46 and a beta of 0.63. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $132.84.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%.

Institutional Investors Weigh In On Cardinal Health

Several institutional investors have recently made changes to their positions in CAH. Eastern Bank acquired a new stake in shares of Cardinal Health in the third quarter valued at about $25,000. Frazier Financial Advisors LLC increased its holdings in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after buying an additional 104 shares in the last quarter. Hara Capital LLC acquired a new stake in shares of Cardinal Health during the 3rd quarter valued at approximately $31,000. AM Squared Ltd purchased a new stake in shares of Cardinal Health during the 3rd quarter worth approximately $33,000. Finally, Kentucky Trust Co acquired a new stake in shares of Cardinal Health in the 4th quarter worth approximately $41,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.61%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.